Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis. 2007 Nov 15; 196 Suppl 2:S390-9.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.